Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study
暂无分享,去创建一个
Phelim Bradley | Zamin Iqbal | Daniel J. Wilson | Julian Parkhill | Stefan Niemann | Tim E A Peto | Thomas A Kohl | Philip Supply | A Sarah Walker | David A Clifton | Daniel J Wilson | Nazir Ismail | Jessica Hedge | Z. Iqbal | D. Clifton | J. Parkhill | S. Niemann | T. Walker | A. Walker | T. Peto | D. Crook | R. Bowden | Camilla L. C. Ip | R. Diel | D. Wilson | F. Drobniewski | K. Niehaus | A. Walker | S. Feuerriegel | P. Bradley | T. Kohl | P. Supply | N. Ismail | C. Gaudin | Derrick W Crook | Rory Bowden | Roland Diel | S. Omar | E. G. Smith | Camilla L C Ip | Timothy M Walker | Georgia Kapatai | E Grace Smith | Silke Feuerriegel | C. del Ojo Elias | Carlos Del Ojo Elias | Shaheed V Omar | Katherine E Niehaus | Francis A Drobniewski | Caroline Allix-Béguec | Cyril Gaudin | J. Hedge | G. Kapatai | C. Allix-Béguec | Carlos del Ojo Elias | Daniel J Wilson | Carlos del Ojo Elias | Carlos Del Ojo Elias | Daniel J. Wilson | Tim E. A. Peto | Derrick W Crook | David A Clifton | Francis A Drobniewski | Grace E Smith | Sarah A Walker | D. Crook | Phelim Bradley | F. Drobniewski | Grace Smith | David A. Clifton | Sarah Walker
[1] Samuel A. Assefa,et al. Elucidating Emergence and Transmission of Multidrug-Resistant Tuberculosis in Treatment Experienced Patients by Whole Genome Sequencing , 2013, PloS one.
[2] Tim E A Peto,et al. Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007–12, with whole pathogen genome sequences: an observational study , 2014, The Lancet. Respiratory medicine.
[3] T. Dallman,et al. Performance comparison of benchtop high-throughput sequencing platforms , 2012, Nature Biotechnology.
[4] K. Kam,et al. Ethambutol Resistance as Determined by Broth Dilution Method Correlates Better than Sequencing Results with embB Mutations in Multidrug-Resistant Mycobacterium tuberculosis Isolates , 2013, Journal of Clinical Microbiology.
[5] E. Böttger. The ins and outs of Mycobacterium tuberculosis drug susceptibility testing. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[6] Jukka Corander,et al. Evolution and transmission of drug resistant tuberculosis in a Russian population , 2014, Nature Genetics.
[7] K. Holt,et al. Out-of-Africa migration and Neolithic co-expansion of Mycobacterium tuberculosis with modern humans , 2013, Nature Genetics.
[8] Y. Balabanova,et al. Rapid diagnostics of tuberculosis and drug resistance in the industrialized world: clinical and public health benefits and barriers to implementation , 2013, BMC Medicine.
[9] A. Crook,et al. Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis. , 2014, The New England journal of medicine.
[10] Jianming Wang,et al. Rapid Diagnosis of Drug Resistance to Fluoroquinolones, Amikacin, Capreomycin, Kanamycin and Ethambutol Using Genotype MTBDRsl Assay: A Meta-Analysis , 2013, PloS one.
[11] M. Pallen,et al. Culture-independent detection and characterisation of Mycobacterium tuberculosis and M. africanum in sputum samples using shotgun metagenomics on a benchtop sequencer , 2014, PeerJ.
[12] S. Borrell,et al. KvarQ: targeted and direct variant calling from fastq reads of bacterial genomes , 2014, BMC Genomics.
[13] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[14] G. Fischer,et al. Next-Generation Ion Torrent Sequencing of Drug Resistance Mutations in Mycobacterium tuberculosis Strains , 2012, Journal of Clinical Microbiology.
[15] B. D. de Jong,et al. A four-month gatifloxacin-containing regimen for treating tuberculosis. , 2015, The New England journal of medicine.
[16] M. Pallen,et al. Whole-Genome Sequencing for Rapid Susceptibility Testing of M. tuberculosis , 2013 .
[17] Linda C. van der Gaag,et al. Probabilistic Graphical Models , 2014, Lecture Notes in Computer Science.
[18] B. Barrell,et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.
[19] Phelim Bradley,et al. Rapid antibiotic resistance predictions from genome sequence data for S. aureus and M. tuberculosis , 2015, bioRxiv.
[20] Martin Goodson,et al. Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads. , 2011, Genome research.
[21] V. Jarlier,et al. Performance of MTBDR plus for detecting high/low levels of Mycobacterium tuberculosis resistance to isoniazid. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[22] George M Church,et al. Tuberculosis Drug Resistance Mutation Database , 2009, PLoS medicine.
[23] J. Musser,et al. Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms , 1997, Antimicrobial agents and chemotherapy.
[24] V. Jarlier,et al. Detection by GenoType MTBDRsl Test of Complex Mechanisms of Resistance to Second-Line Drugs and Ethambutol in Multidrug-Resistant Mycobacterium tuberculosis Complex Isolates , 2010, Journal of Clinical Microbiology.
[25] F. Dafae,et al. Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence setting , 2012, BMC Microbiology.
[26] Daniel J. Wilson,et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study , 2013, The Lancet. Infectious diseases.
[27] Michael Eisenstein,et al. Oxford Nanopore announcement sets sequencing sector abuzz , 2012, Nature Biotechnology.
[28] L. Gabbasova,et al. Global tuberculosis report (2014) , 2014 .
[29] W. Sougakoff,et al. Crystal Structure of the Pyrazinamidase of Mycobacterium tuberculosis: Insights into Natural and Acquired Resistance to Pyrazinamide , 2011, PloS one.
[30] Phelim Bradley,et al. Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis , 2015, Nature Communications.
[31] Alexandros Stamatakis,et al. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies , 2014, Bioinform..
[32] G. Kahlmeter,et al. Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis. , 2012, Bulletin of the World Health Organization.
[33] S. Niemann,et al. Mycobacterium tuberculosis Pyrazinamide Resistance Determinants: a Multicenter Study , 2014, mBio.
[34] W. Hanage,et al. Comprehensive Identification of Single Nucleotide Polymorphisms Associated with Beta-lactam Resistance within Pneumococcal Mosaic Genes , 2014, PLoS genetics.
[35] G. McVean,et al. De novo assembly and genotyping of variants using colored de Bruijn graphs , 2011, Nature Genetics.
[36] Razvan Sultana,et al. Genomic Analysis Identifies Targets of Convergent Positive Selection in Drug Resistant Mycobacterium tuberculosis , 2013, Nature Genetics.
[37] K. Floyd,et al. Rapid molecular TB diagnosis: evidence, policy-making and global implementation of Xpert®MTB/RIF Weyer, , 2013 .
[38] Daniel J. Wilson,et al. ClonalFrameML: Efficient Inference of Recombination in Whole Bacterial Genomes , 2015, PLoS Comput. Biol..